Innospec (IOSP) Liabilities and Shareholders Equity (2010 - 2026)

Innospec's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 2.55% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $7.3 billion (up 3.57% YoY), while the FY2025 annual figure was $1.8 billion, up 5.63% from the prior year.
• Liabilities and Shareholders Equity came in at $1.8 billion for Q1 2026 at Innospec, down from $1.8 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.8 billion in Q4 2025 to a low of $1.6 billion in Q4 2022.
• A 5-year average of $1.7 billion and a median of $1.7 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity grew 13.86% in 2022 and retreated 3.03% in 2023, its largest moves.
• Innospec's Liabilities and Shareholders Equity stood at $1.6 billion in 2022, then climbed by 6.47% to $1.7 billion in 2023, then gained by 1.6% to $1.7 billion in 2024, then gained by 5.63% to $1.8 billion in 2025, then declined by 0.69% to $1.8 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $1.8 billion, $1.8 billion, and $1.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison